UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

The clinical progress of mRNA vaccines and immunotherapies

Nature biotechnology, 2022-06, Vol.40 (6), p.840-854

2022

Volltextzugriff (PDF)

Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency

The New England journal of medicine, 2019-09, Vol.381 (10), p.933-944

2019

Volltextzugriff (PDF)

A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II

Genetics in medicine, 2016-01, Vol.18 (1), p.73-81

2016

Volltextzugriff (PDF)

A New Class of Diamine-Based Human Histamine H3 Receptor Antagonists: 4-(Aminoalkoxy)benzylamines

Journal of medicinal chemistry, 2003-08, Vol.46 (18), p.3938-3944

2003

Volltextzugriff (PDF)

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling

Bioorganic & medicinal chemistry, 2008-03, Vol.16 (6), p.2968-2973

2008

Volltextzugriff (PDF)

A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA

Molecular genetics and metabolism, 2016-07, Vol.118 (3), p.198-205

2016

Volltextzugriff (PDF)

Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor

European journal of pharmacology, 2007-12, Vol.576 (1-3), p.43-54

2007

Volltextzugriff (PDF)

Dual serotonin transporter/histamine H3 ligands : Optimization of the H3 pharmacophore

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.702-706

2007

Volltextzugriff (PDF)

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

British journal of pharmacology, 2006-05, Vol.148 (1), p.102-113

2006

Volltextzugriff (PDF)

Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers

Clinical pharmacology in drug development, 2019-02, Vol.8 (2), p.246-259

2019

Volltextzugriff (PDF)

Aplysamine-1 and related analogs as histamine H3 receptor antagonists

Bioorganic & medicinal chemistry letters, 2006-02, Vol.16 (4), p.897-900

2006

Volltextzugriff (PDF)

Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions

Molecular genetics and metabolism, 2016-06, Vol.118 (2), p.65-69

2016

Volltextzugriff (PDF)

Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand

Nuclear medicine and biology, 2006-08, Vol.33 (6), p.801-810

2006

Volltextzugriff (PDF)

Behavioral Characterization of Mice Lacking Histamine H3 Receptors

Molecular pharmacology, 2002-08, Vol.62 (2), p.389

2002

Volltextzugriff (PDF)

Patient Voice in Rare Disease Drug Development and Endpoints

Therapeutic innovation & regulatory science, 2017-03, Vol.51 (2), p.257-263

2017

Volltextzugriff (PDF)

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors

Bioorganic & medicinal chemistry letters, 2007-05, Vol.17 (9), p.2603-2607

2007

Volltextzugriff (PDF)

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

European journal of pharmacology, 2008-06, Vol.587 (1), p.141-146

2008

Volltextzugriff (PDF)

4-Phenoxypiperidines: Potent, Conformationally Restricted, Non-Imidazole Histamine H3 Antagonists

Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.2229-2238

2005

Volltextzugriff (PDF)

Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development

ACS medicinal chemistry letters, 2015-04, Vol.6 (4), p.450-454

2015

Volltextzugriff (PDF)

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

European journal of medicinal chemistry, 2009-11, Vol.44 (11), p.4413-4425

2009

Volltextzugriff (PDF)

Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors

Bioorganic & medicinal chemistry letters, 2007-08, Vol.17 (15), p.4374-4377

2007

Volltextzugriff (PDF)

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors

Bioorganic & medicinal chemistry letters, 2007-05, Vol.17 (9), p.2603-2607

2007

Volltextzugriff (PDF)

Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (1), p.39-43

2008

Volltextzugriff (PDF)

Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (4), p.1047-1051

2007

Volltextzugriff (PDF)

Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors

Bioorganic & medicinal chemistry letters, 2007-05, Vol.17 (9), p.2566-2569

2007

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionTaylor & Francis

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(86)

Sprache

Englisch
(91)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(26)
Animals
(25)
Pharmacology & Pharmacy
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(18)
Pharmacology. Drug Treatments
(18)
Rats
(17)
Histamine
(15)
Chemistry, Medicinal
(14)
Neuropharmacology
(14)
Physical Sciences
(13)
Neurotransmitters. Neurotransmission. Receptors
(12)
Serotonin
(12)
Chemistry
(11)
Histamine Antagonists - Pharmacology
(11)
Chemistry, Organic
(10)
Male
(10)
Histamine Antagonists - Chemical Synthesis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The clinical progress of mRNA vaccines and immunotherapies

Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency

A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II

A New Class of Diamine-Based Human Histamine H3 Receptor Antagonists: 4-(Aminoalkoxy)benzylamines

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling

A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA

Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor

Dual serotonin transporter/histamine H3 ligands : Optimization of the H3 pharmacophore

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers

Aplysamine-1 and related analogs as histamine H3 receptor antagonists

Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions

Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand

Behavioral Characterization of Mice Lacking Histamine H3 Receptors

Patient Voice in Rare Disease Drug Development and Endpoints

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

4-Phenoxypiperidines: Potent, Conformationally Restricted, Non-Imidazole Histamine H3 Antagonists

Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors

Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors

Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors

Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors

Aktive Filter

Suchergebnisse filtern